Early estimation of the case fatality rate of COVID-19 in mainland China: a data-driven analysis
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
BACKGROUND: An ongoing outbreak of pneumonia caused by a novel coronavirus [severe acute respiratory syndrome coronavirus (SARS-CoV)-2], named COVID-19, hit a major city of China, Wuhan in December 2019 and subsequently spread to other provinces/regions of China and overseas. Several studies have been done to estimate the basic reproduction number in the early phase of this outbreak, yet there are no reliable estimates of case fatality rate (CFR) for COVID-19 to date. METHODS: In this study, we used a purely data-driven statistical method to estimate the CFR in the early phase of the COVID-19 outbreak. Daily numbers of laboratory-confirmed COVID-19 cases and deaths were collected from January 10 to February 3, 2020 and divided into three clusters: Wuhan city, other cities of Hubei province, and other provinces of mainland China. Simple linear regression model was applied to estimate the CFR from each cluster. RESULTS: We estimated that CFR during the first weeks of the epidemic ranges from 0.15% (95% CI: 0.12-0.18%) in mainland China excluding Hubei through 1.41% (95% CI: 1.38-1.45%) in Hubei province excluding the city of Wuhan to 5.25% (95% CI: 4.98-5.51%) in Wuhan. CONCLUSIONS: Our early estimates suggest that the CFR of COVID-19 is lower than the previous coronavirus epidemics caused by SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
A novel coronavirus outbreak of global health concern
Wang, C., Horby, P. W., Hayden, F. G., & Gao, G. F. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30185-9 · Cited by 7,700 · cited 1×
“On December 31, 2019, the discovery of a novel coronav i rus (SARS-CoV-2)- in fec ted pneumonia (COVID-19) in Wuhan, China, was reported to the World Health Organization (WHO) and has caused serious illness and death (1).”
BackgroundWu, J. T., Leung, K., & Leung, G. M. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30260-9 · Cited by 4,389 · cited 1×
“Although several studies have been done to estimate the basic reproduction number in the early phase of this outbreak, there is still lack of reliable estimates of CFR for COVID-19 to date (7-9).”
SARS and MERS: recent insights into emerging coronaviruses
de Wit, E., van Doremalen, N., Falzarano, D., & Munster, V. J. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.81 · Cited by 3,510 · cited 2×
“Ann Transl Med 2020;8(4):128 | http://dx.”
BackgroundFrom SARS to MERS, Thrusting Coronaviruses into the Spotlight
Song, Z., Xu, Y., Bao, L., Zhang, L., Yu, P., Qu, Y., Zhu, H., Zhao, W., Han, Y., & Qin, C. (2019) · Viruses · doi:10.3390/v11010059 · Cited by 1,265 · cited 1×
“In the 21 century, two highly pathogenic human coronaviruses, the severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV), have caused global epidemics with more than 10,000 cumulative cases in the past two decades (4,5).”
BackgroundThe Novel Coronavirus Originating in Wuhan, China: Challenges for Global Health Governance
Phelan, A. L., Katz, R., & Gostin, L. O. (2020) · JAMA · doi:10.1001/jama.2020.1097 · Cited by 1,207 · cited 1×
“Since the epidemic situation in Wuhan has been further aggravated, the Chinese Government has implemented metropolitan-wide quarantine of Wuhan and several nearby cities from January 23, 2020 (15).”
BackgroundWallinga, J. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh255 · Cited by 1,197 · cited 1×
“The basic reproduction number (R0) and best estimates of case-fatality rates (CFR) are two key parameters to understand the basic epidemiological features of the outbreak (6).”
BackgroundDonnelly, C. A., Ghani, A. C., Leung, G. M., Hedley, A. J., Fraser, C., Riley, S., Abu-Raddad, L. J., Ho, L.-M., Thach, T.-Q., Chau, P., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13410-1 · Cited by 940
Zhao, S., Musa, S. S., Lin, Q., Ran, J., Yang, G., Wang, W., Lou, Y., Yang, L., Gao, D., He, D., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020388 · Cited by 439 · cited 1×
“Although several studies have been done to estimate the basic reproduction number in the early phase of this outbreak, there is still lack of reliable estimates of CFR for COVID-19 to date (7-9).”
BackgroundSelf-citationThe Novel Coronavirus Originating in Wuhan, China: Challenges for Global Health Governance
Phelan, A., Katz, R., & Gostin, L. O. (2020) · Scholarship - GEORGETOWN LAW (Georgetown University) · Cited by 268
The methodological and reporting quality of systematic reviews from China and the USA are similar
Tian, J., Zhang, J., Ge, L., Yang, K., & Song, F. (2017) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2016.12.004 · Cited by 248 · cited 1×
“Our findings could be used to inform guideline development, systematic review and knowledge translation programs (18-20).”
BackgroundThe quality of evidence in Chinese meta-analyses needs to be improved
Yao, L., Sun, R., Chen, Y.-L., Wang, Q., Wei, D., Wang, X., & Yang, K. (2016) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2016.01.003 · Cited by 180 · cited 1×
“Our findings could be used to inform guideline development, systematic review and knowledge translation programs (18-20).”
BackgroundSelf-citationFisman, D., Rivers, C., Lofgren, E., & Majumder, M. S. (2014) · PLoS Currents · doi:10.1371/currents.outbreaks.98d2f8f3382d84f390736cd5f5fe133c · Cited by 165
Editorial: can China master the guideline challenge?
Yang, K., Chen, Y., Li, Y., Schünemann, H. J., & Symposium, M. O. T. L. I. G. (2013) · Health Research Policy and Systems · doi:10.1186/1478-4505-11-1 · Cited by 122 · cited 1×
“Our findings could be used to inform guideline development, systematic review and knowledge translation programs (18-20).”
BackgroundSelf-citationCase fatality of SARS in mainland China and associated risk factors
Jia, N., Feng, D., Fang, L., Richardus, J. H., Xiao-na, H., Cao, W., & de Vlas, S. J. (2009) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2008.02147.x · Cited by 87 · cited 1×
“4% in mainland China) (10,11) and MERS-CoV (CFR: 34.”
Cited by
Abd El-Aziz, T. M., & Stockand, J. D. (2020) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2020.104327 · Cited by 363
Metadata
- Authors
- on behalf of COVID-19 evidence and recommendations working group, Yang, S., Cao, P., Du, P., Wu, Z., Zhuang, Z., Yang, L., Yu, X., Zhou, Q., Feng, X., Wang, X., Li, W., Liu, E., Chen, J., Chen, Y., & He, D.
- Venue
- Annals of Translational Medicine
- Publisher
- AME Publishing Company
- Published
- 2020-02
- Volume
- 8
- Issue
- 4
- Pages
- 128-128
- ISSN
- 2305-5839 (ISSN-L)
- 2305-5847
- OpenAlex
- W3008815382
- Cited by
- 187
- References
- 15
- FWCI
- 6.97
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.